
Venmax Drugs And Pharmaceuticals Limited
Produces and trades pharmaceuticals, chemicals, and biotech products in India.
Produces and trades pharmaceuticals, chemicals, and biotech products in India.
Venmax Drugs And Pharmaceuticals Limited (VDAPL) is a Public Limited Indian Non-Government Company incorporated in India on 28 September 1988 and has a history of 36 years and five months. Its registered office is in Hyderabad, Telangana, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 531015.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 5.24 Cr.
The company has closed loans amounting to ₹6.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Venmax Drugs And Pharmaceuticals Limited India are Pratibha Jhawar as COMPANY SECRETARY and Sai Kummarikuntla as Cfo. Sadhanala Rao, Dasi Rakesh, Swapneswar Mishra, and Two other members serve as directors at the Company.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
L24230TG1988PLC009102
009102
BSE : 531015
Public Limited Indian Non-Government Company
28 Sep 1988
06 Sep 2023
31 Mar 2023
Listed
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pratibha Jhawar | Company Secretary | 02-Sep-2024 | Current |
Sai Kummarikuntla | CFO | 03-Sep-2024 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sadhanala Rao ![]() | Additional Director | 01-Oct-2024 | Current |
Dasi Rakesh ![]() | Additional Director | 22-Aug-2024 | Current |
Swapneswar Mishra ![]() | Additional Director | 16-Jan-2024 | Current |
Gundluru Reddeppa ![]() | Additional Director | 22-Aug-2024 | Current |
Pilli Kumari | Additional Director | 16-Jan-2024 | Current |
Venmax Drugs And Pharmaceuticals Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 20.42% decrease. The company also saw a substantial fall in profitability, with a 72.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.95%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2017, Venmax Drugs And Pharmaceuticals had a promoter holding of 23.13% and a public holding of 76.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Gundluru Reddeppa is a mutual person
Sadhanala Rao, Dasi Rakesh and 1 more are mutual person
Sadhanala Rao is a mutual person
Sadhanala Rao is a mutual person
Dasi Rakesh and Swapneswar Mishra are mutual person
Dasi Rakesh is a mutual person
₹0
₹6.50 Cr
Date | Lender | Amount | Status |
---|---|---|---|
11 Jul 2008 | Union Bank Of India | ₹1.50 Cr | Satisfied |
17 Aug 1999 | A.P. State Financial Corporation | ₹1.43 Cr | Satisfied |
02 Aug 1999 | A.P. Industrial Development Corporation Ltd. | ₹7.00 M | Satisfied |
20 Aug 1991 | A.P. State Financial Corporation | ₹5.60 M | Satisfied |
13 Aug 1991 | A.P. State Financial Corporation | ₹0.62 M | Satisfied |
Venmax Drugs And Pharmaceuticals has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Venmax Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venmax Drugs And Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sadhanala Venkata Rao was appointed as a Additional Director was appointed as a Additional Director on 01 Oct 2024 & has been associated with this company since 5 months 10 days .
Sai Baba Kummarikuntla was appointed as a Cfo was appointed as a Cfo on 03 Sep 2024 & has been associated with this company since 6 months 8 days .
Pratibha Jhawar was appointed as a Company Secretary was appointed as a Company Secretary on 02 Sep 2024 & has been associated with this company since 6 months 9 days .
Dasi Reddy Rakesh was appointed as a Additional Director was appointed as a Additional Director on 22 Aug 2024 & has been associated with this company since 6 months 20 days .
Gundluru Reddeppa was appointed as a Additional Director was appointed as a Additional Director on 22 Aug 2024 & has been associated with this company since 6 months 20 days .
Venmax Drugs And Pharmaceuticals Limited last Annual general meeting of members was held on 06 Sep 2023 as per latest MCA records.
Venmax Drugs And Pharmaceuticals Limited was incorporated on 28 Sep 1988.
The authorized share capital of Venmax Drugs And Pharmaceuticals Limited is ₹ 8.00 Cr and paid-up capital is ₹ 5.24 Cr.
Currently 7 directors are associated with Venmax Drugs And Pharmaceuticals Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Venmax Drugs And Pharmaceuticals Limited is Shed No.22 Plot No.84, Phase - 1 Ida Cherlapally India, Hyderabad, Telangana, 500051.
The corporate identification number (CIN) of Venmax Drugs And Pharmaceuticals Limited is L24230TG1988PLC009102 and the company number is 009102 as per Ministry of Corporate Affairs (MCA).
Yes, Venmax Drugs And Pharmaceuticals Limited is registered on Bombay Stock Exchange (BSE).
According to the financial reports for the fiscal year 2016, the revenue trend for Venmax Drugs And Pharmaceuticals Limited has fallen by -20.42%.
The financial reports for the fiscal year 2016 indicates that The net worth of Venmax Drugs And Pharmaceuticals Limited has experienced an downturn of -40.95%.
The most recent Balance Sheet for Venmax Drugs And Pharmaceuticals Limited was filed with the ROC on 31 Mar 2023.
RR
RA
GG
RV